Evaluation of GD2 expression in patients with osteosarcoma

被引：0
|
作者：
Tarim, John [1 ]
Sowers, Rebecca S. [1 ]
Piperdi, Sajida [1 ]
Khanna, Chand [2 ]
Gorlick, Richard G. [1 ]
机构：
[1] Childrens Hosp Montefiore, Bronx, NY USA
[2] NCI, Bethesda, MD 20892 USA
来源：
CANCER RESEARCH | 2011年 / 71卷
关键词：
D O I：
10.1158/1538-7445.AM2011-5332
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5332
引用
收藏
页数：1
相关论文
共 50 条
  • [21] PATTERNS OF EXPRESSION OF DISIALOGANGLIOSIDE GD2 IN PEDIATRIC SARCOMAS
    Murphy, Lindsey
    Albert, Catherine
    Park, Julie
    Hawkins, Doug
    Rudzinski, Erin
    Pinto, Navin
    PEDIATRIC BLOOD & CANCER, 2018, 65
  • [22] EXPRESSION OF GD2 TUMOR-ANTIGEN IN RETINOBLASTOMA
    LEE, TC
    ABRAMSON, DH
    CHEUNG, NKV
    MACLEISH, PR
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1995, 36 (04) : S221 - S221
  • [23] Expression of Ganglioside GD2 on Colorectal Adenocarcinoma Cells
    Lupatov, A. Yu.
    Gisina, A. M.
    Kim, Y. S.
    Bykasov, S. A.
    Volchenko, N. N.
    Sidorov, D. V.
    Yarygin, K. N.
    Kholodenko, R. V.
    BIOCHEMISTRY MOSCOW-SUPPLEMENT SERIES B-BIOMEDICAL CHEMISTRY, 2020, 14 (03) : 272 - 276
  • [24] Enhancement of malignant properties of human osteosarcoma cells with disialyl gangliosides GD2/GD3
    Shibuya, Hidenobu
    Hamamura, Kazunori
    Hotta, Hiroshi
    Matsumoto, Yasuyuki
    Nishida, Yoshihiro
    Hattori, Hisashi
    Furukawa, Keiko
    Ueda, Minoru
    Furukawa, Koichi
    CANCER SCIENCE, 2012, 103 (09) : 1656 - 1664
  • [25] Expression of Disialoganglioside (GD2) in Neuroblastic Tumors: A Prognostic Value for Patients Treated With Anti-GD2 Immunotherapy
    Terzic, Tatjana
    Cordeau, Martine
    Herblot, Sabine
    Teira, Pierre
    Cournoyer, Sonia
    Beaunoyer, Mona
    Peuchmaur, Michel
    Duval, Michel
    Sartelet, Herve
    PEDIATRIC AND DEVELOPMENTAL PATHOLOGY, 2018, 21 (04) : 355 - 362
  • [26] Humanized GD2 antibody for targeted radiopharmaceutical therapy of human and canine osteosarcoma.
    Fu, Yingli
    Yu, Jing
    Liatsou, Ioanna
    Josefsson, Anders
    Du, Yong
    Bryan, Jeffrey
    Kraitchman, Dara L.
    Sgouros, George
    CANCER RESEARCH, 2021, 81 (13)
  • [27] Ganglioside (GD2) expression and intermediary filaments in astrocytic tumors
    Mennel, HD
    Lell, B
    CLINICAL NEUROPATHOLOGY, 2005, 24 (01) : 13 - 18
  • [28] EXPRESSION OF GD2 GANGLIOSIDE BY UNTREATED PRIMARY HUMAN NEUROBLASTOMAS
    WU, ZL
    SCHWARTZ, E
    SEEGER, R
    LADISCH, S
    CANCER RESEARCH, 1986, 46 (01) : 440 - 443
  • [29] GD2 is a macrophage checkpoint molecule and combined GD2/CD47 blockade results in synergistic effects and tumor clearance in xenograft models of neuroblastoma and osteosarcoma
    Theruvath, Johanna
    Smith, Benjie
    Linde, Miles H.
    Sotillo, Elena
    Heitzeneder, Sabine
    Marjon, Kristopher
    Tousley, Aidan
    Lattin, Jake
    Banuelos, Allison
    Dhingra, Shaurya
    Murty, Surya
    Mackall, Crystal L.
    Majzner, Robbie G.
    CANCER RESEARCH, 2020, 80 (14) : 35 - 35
  • [30] GD2 or HER2 targeting T cell engaging bispecific antibodies to treat osteosarcoma
    Jeong A. Park
    Nai-Kong V. Cheung
    Journal of Hematology & Oncology, 13
12345